Cargando…
Suppression of TGF‐β/Smad2 signaling by GW788388 enhances DENV‐2 clearance in macrophages
Dengue fever, caused by the dengue virus (DENV‐1, −2, −3, and −4), affects millions of people in the tropical and subtropical regions worldwide. Severe dengue is correlated with high viraemia and cytokine storm, such as high levels of transforming growth factor‐β1 (TGF‐β1) in the patient's seru...
Autores principales: | Teixeira, Gabrielly Sbano, Andrade, Audrien Alves, Torres, Lauana Ribas, Couto‐Lima, Dinair, Moreira, Otacilio C., Abreu, Rayane, Waghabi, Mariana Caldas, de Souza, Elen Mello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544077/ https://www.ncbi.nlm.nih.gov/pubmed/35596058 http://dx.doi.org/10.1002/jmv.27879 |
Ejemplares similares
-
Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease
por: de Oliveira, Fabiane L., et al.
Publicado: (2012) -
Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells
por: Lho, Yunmee, et al.
Publicado: (2021) -
Inhibition of Brazilian ZIKV strain replication in primary human placental chorionic cells and cervical cells treated with nitazoxanide
por: de Souza, Audrien A.A., et al.
Publicado: (2020) -
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease
por: Waghabi, Mariana Caldas, et al.
Publicado: (2022) -
TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2019)